William Marshall
Directeur/Membre du Conseil chez BiOptix Diagnostics, Inc.
Postes actifs de William Marshall
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
BiOptix Diagnostics, Inc.
 BiOptix Diagnostics, Inc. Electronic Equipment/InstrumentsElectronic Technology BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO. | Directeur/Membre du Conseil | 18/10/2009 | - |
| Independent Dir/Board Member | - | - | |
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Directeur/Membre du Conseil | - | - |
FluoroFinder LLC
 FluoroFinder LLC Packaged SoftwareTechnology Services FluoroFinder LLC designs and develops flow cytometry products for research facilities. It offers flow cytometry, microscopy, and concierge services. The company was founded by Roland Marcus in 2014 and is headquartered in Boulder, CO. | Directeur/Membre du Conseil | - | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Directeur/Membre du Conseil | - | - |
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Part of GSK Plc, Elsie Biotechnologies Inc. is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics. The company is based in San Diego, CA. Elsie Biotechnologies integrates discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery of oligonucleotide therapeutics. The company's platform accesses the entire oligonucleotide chemistry space to optimize gene silencing and splice switching, and develops novel oligonucleotide therapeutics that are more potent, safer, and easier to deliver to target tissues. Elsie Biotechnologies is focused on unlocking the full potential of RNA therapeutics to treat undruggable diseases. The company was founded in 2021 by Phil Baran and Philip E. Dawson. The CEO is Kevin Green. Elsie Biotechnologies was acquired by GSK Plc on June 06, 2024 for $50 million. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Historique de carrière de William Marshall
Anciens postes connus de William Marshall
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/02/2017 | 13/09/2020 |
| Directeur Général | 13/02/2017 | 13/09/2020 | |
| Fondateur | 13/02/2017 | 13/09/2020 | |
| President | 13/02/2017 | 13/09/2020 | |
| THERMO FISHER SCIENTIFIC | Directeur Technique/Scientifique/R&D | 01/04/2005 | 01/07/2007 |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Directeur des opérations | 01/08/2002 | 01/04/2005 |
| Directeur Technique/Scientifique/R&D | 01/08/2002 | 01/04/2005 | |
| Fondateur | 01/08/2002 | 01/04/2005 | |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/1992 | 01/01/2002 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de William Marshall
| University of Colorado Boulder | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 12 |
Opérationnelle
| Director/Board Member | 7 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
Sectorielle
| Health Technology | 7 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| AMGEN INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Commercial Services |
BiOptix Diagnostics, Inc.
BiOptix Diagnostics, Inc. Electronic Equipment/InstrumentsElectronic Technology BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO. | Electronic Technology |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | Health Technology |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
FluoroFinder LLC
FluoroFinder LLC Packaged SoftwareTechnology Services FluoroFinder LLC designs and develops flow cytometry products for research facilities. It offers flow cytometry, microscopy, and concierge services. The company was founded by Roland Marcus in 2014 and is headquartered in Boulder, CO. | Technology Services |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Part of GSK Plc, Elsie Biotechnologies Inc. is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics. The company is based in San Diego, CA. Elsie Biotechnologies integrates discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery of oligonucleotide therapeutics. The company's platform accesses the entire oligonucleotide chemistry space to optimize gene silencing and splice switching, and develops novel oligonucleotide therapeutics that are more potent, safer, and easier to deliver to target tissues. Elsie Biotechnologies is focused on unlocking the full potential of RNA therapeutics to treat undruggable diseases. The company was founded in 2021 by Phil Baran and Philip E. Dawson. The CEO is Kevin Green. Elsie Biotechnologies was acquired by GSK Plc on June 06, 2024 for $50 million. | Health Technology |
- Bourse
- Insiders
- William Marshall
- Expérience
